Clinical Trial Update: IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous busulfan with allogeneic hematopoietic stem cell transplant for patients with myelodysplastic syndrome and acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2021-01-19